(Q36666966)

English

NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes

scientific article published on November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

Lenard M Lichtenberger

1

1 reference

Europe PubMed Central

15 August 2017

Yong Zhou

2

1 reference

Europe PubMed Central

15 August 2017

Elizabeth J Dial

3

1 reference

Europe PubMed Central

15 August 2017

Robert M Raphael

4

1 reference

Europe PubMed Central

15 August 2017

publication date

1 November 2006

1 reference

Europe PubMed Central

15 August 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

15 August 2017

58

1 reference

Europe PubMed Central

15 August 2017

11

1 reference

Europe PubMed Central

15 August 2017

1421-1428

1 reference

Europe PubMed Central

15 August 2017

Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Lipid composition and the lateral pressure profile in bilayers

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Elastic area compressibility modulus of red cell membrane

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Dynamic Tension Spectroscopy and Strength of Biomembranes

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Effect of anti-inflammatory drugs on splenocyte membrane fluidity.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Effects of diclofenac on EPC liposome membrane properties

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Physical principles of membrane organization

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Duodenal alkaline secretion: its mechanisms and role in mucosal protection against gastric acid

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

The hydrophobic barrier properties of gastrointestinal mucus

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

The influence of short-chain alcohols on interfacial tension, mechanical properties, area/molecule, and permeability of fluid lipid bilayers

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

A membrane bending model of outer hair cell electromotility

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Effect of chain length and unsaturation on elasticity of lipid bilayers

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Membrane permeabilization by non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Material property characteristics for lipid bilayers containing lysolipid

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Effect of salicylate on the elasticity, bending stiffness, and strength of SOPC membranes

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.10.0001

21 January 2018

Identifiers

10.1211/JPP.58.10.0001

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36666966&oldid=2113170752"